Skip to main content

Table 1 Quality control of candidate S-OIV H1N1 and NIBRG-14 H5N1 vaccines

From: Characterization of cross protection of Swine-Origin Influenza Virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB/c mice given a single-dose vaccination

Test items

Summary of results

Notes

Abnormal toxicity

S-OIV pass, H5N1 not done

Body weight of tested mice increased

Antigenicity

HAI titer: S-OIV 128 ~ 256

Also interacted with NIBSC sntisera

H5N1 1024

 

Endotoxin

S-OIV Between 28 ~ 51,

International criteria: ≤ 200 EU/ml

H5N1 31.4 EU/ml,

 

Ovalbumin

S-OIV ≈ 4 μg/ml,

Europe: ≤ 2 μg/ml; WHO: ≤ 5 μg/ml

H5N1 55 μg/ml

 

Formaldehyde

S-OIV 0.373 ~ 0.548 μg/ml,

WHO: ≤ 0.02% ~0.01% (≈1 mg/ml)

H5N1 not done

 
  1. Note: Result showed that all items evaluated for quality control of produced candidate vaccine fit the demand of international criteria.